Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease

被引:52
|
作者
Gosselet, Fabien
Saint-Pol, Julien
Fenart, Laurence
机构
[1] Univ Lille Nord France, Lille, France
[2] UArtois, LBHE, EA 2465, Lens, France
[3] IMPRT IFR114, Lille, France
关键词
Oxysterols; Blood-brain barrier; ABCA1; ABCB1; Alzheimer's disease; LXR; CAPILLARY ENDOTHELIAL-CELLS; AMYLOID-BETA-PEPTIDE; BODY CHOLESTEROL METABOLISM; TO-BASOLATERAL TRANSPORT; TRANSGENIC MOUSE MODEL; P-GLYCOPROTEIN; IN-VITRO; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATIVE DISEASES;
D O I
10.1016/j.bbrc.2013.11.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered brain cholesterol homeostasis plays a key role in neurodegenerative diseases such as Alzheimer's disease (AD). For a long time, the blood-brain barrier (BBB) was basically considered as a barrier isolating the brain from circulating cholesterol, however, several lines of evidence now suggest that the BBB strictly regulates the exchanges of sterol between the brain and the peripheral circulation. Oxysterols, synthesized by neurons or by peripheral cells, cross the BBB easily and modulate the expression of several enzymes, receptors and transporters which are involved not only in cholesterol metabolism but also in other brain functions. This review article deals with the way oxysterols impact BBB cells. These perspectives open new routes for designing certain therapeutical approaches that target the BBB so that the onset and/or progression of brain diseases such as AD may be modulated. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 50 条
  • [21] The Impairment of Blood-Brain Barrier in Alzheimer's Disease: Challenges and Opportunities with Stem Cells
    Lopez-Ornelas, Adolfo
    Jimenez, Adriana
    Perez-Sanchez, Gilberto
    Rodriguez-Perez, Citlali Ekaterina
    Corzo-Cruz, Alejandro
    Velasco, Ivan
    Estudillo, Enrique
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [22] Proteomic alterations in the brain and blood-brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer's disease
    Ito, Shingo
    Yagi, Ryotaro
    Ogata, Seiryo
    Masuda, Takeshi
    Saito, Takashi
    Saido, Takaomi
    Ohtsuki, Sumio
    FLUIDS AND BARRIERS OF THE CNS, 2023, 20 (01)
  • [23] Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models
    Matsuo, Kinya
    Nshihara, Hideaki
    NEURAL REGENERATION RESEARCH, 2024, 19 (09) : 1954 - 1960
  • [24] Pericyte Control of Gene Expression in the Blood-Brain Barrier Endothelium: Implications for Alzheimer's Disease
    Nelson, Doug
    Thompson, Kevin J.
    Wang, Lushan
    Wang, Zengtao
    Eberts, Paulina
    Azarin, Samira M.
    Kalari, Krishna R.
    Kandimalla, Karunya K.
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 99 : S281 - S297
  • [25] Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
    Zipser, B. D.
    Johanson, C. E.
    Gonzalez, L.
    Berzin, T. M.
    Tavares, R.
    Hulette, C. M.
    Vitek, M. P.
    Hovanesian, V.
    Stopa, E. G.
    NEUROBIOLOGY OF AGING, 2007, 28 (07) : 977 - 986
  • [26] ApoE4-mediated blood-brain barrier damage in Alzheimer's disease: Progress and prospects
    Zhou, Xuebin
    Shi, Qiyuan
    Zhang, Xinyue
    Gu, Lili
    Li, Jinhua
    Quan, Shengli
    Zhao, Xia
    Li, Qin
    BRAIN RESEARCH BULLETIN, 2023, 199
  • [27] A Leaky Blood-Brain Barrier to Fibrinogen Contributes to Oxidative Damage in Alzheimer's Disease
    McLarnon, James G.
    ANTIOXIDANTS, 2022, 11 (01)
  • [28] Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance
    Nehra, Geetika
    Bauer, Bjoern
    Hartz, Anika M. S.
    PHARMACOLOGY & THERAPEUTICS, 2022, 234
  • [29] Transport of apolipoproteins E and J at the blood-brain barrier - Relevance to Alzheimer's disease
    Martel, CL
    Ghiso, J
    Frangione, B
    Zlokovic, BV
    STP PHARMA SCIENCES, 1997, 7 (01): : 28 - 36
  • [30] Alzheimer's disease drug development and the problem of the blood-brain barrier
    Pardridge, William A.
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 427 - 432